Advanced search
Publication Cover
Emerging Microbes & Infections Volume 11, 2022 - Issue 1
Submit an article Journal homepage
6,287
Views
36
CrossRef citations to date
0
Altmetric
Coronaviruses

Real-world effectiveness of homologous and heterologous BNT162b2, CoronaVac, and AZD1222 booster vaccination against Delta and Omicron SARS-CoV-2 infection

Jing Lian Suaha Institute for Clinical Research, National Institutes of Health, Ministry of Health Malaysia, Shah Alam, MalaysiaORCID Iconhttps://orcid.org/0000-0003-0908-3597
ORCID Icon,
Boon Hwa Tnga Institute for Clinical Research, National Institutes of Health, Ministry of Health Malaysia, Shah Alam, Malaysia
,
Peter Seah Keng Toka Institute for Clinical Research, National Institutes of Health, Ministry of Health Malaysia, Shah Alam, MalaysiaORCID Iconhttps://orcid.org/0000-0003-3663-450X
ORCID Icon,
Masliyana Husina Institute for Clinical Research, National Institutes of Health, Ministry of Health Malaysia, Shah Alam, MalaysiaORCID Iconhttps://orcid.org/0000-0002-6553-6012
ORCID Icon,
Thevesh Thevananthanb Disease Control Division, Ministry of Health Malaysia, Putrajaya, Malaysia
,
Kalaiarasu M. Peariasamya Institute for Clinical Research, National Institutes of Health, Ministry of Health Malaysia, Shah Alam, MalaysiaORCID Iconhttps://orcid.org/0000-0001-9279-3498
ORCID Icon &
Sheamini Sivasampua Institute for Clinical Research, National Institutes of Health, Ministry of Health Malaysia, Shah Alam, MalaysiaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-2314-6048
ORCID Icon show all
Pages 1343-1345 | Received 06 Apr 2022, Accepted 28 Apr 2022, Published online: 23 May 2022

References

  • Cheng SMS, Mok CKP, Leung YWY, et al. Neutralizing antibodies against the SARS-CoV-2 Omicron variant following homologous and heterologous CoronaVac or BNT162b2 vaccination. Nat Med. 2022;28:486–489.
  • Pérez-Then E, Lucas C, Monteiro VS, et al. Neutralizing antibodies against the SARS-CoV-2 Delta and Omicron variants following heterologous CoronaVac plus BNT162b2 booster vaccination. Nat Med. 2022;28:481–485.
  • Accorsi EK, Britton A, Fleming-Dutra KE, et al. Association between 3 doses of mRNA COVID-19 Vaccine and symptomatic infection caused by the SARS-CoV-2 Omicron and Delta variants. JAMA. 2022;327(7):639–651.
  • Nemet I, Kliker L, Lustig Y, et al. Third BNT162b2 vaccination neutralization of SARS-CoV-2 Omicron infection. N Engl J Med. 2022;386(5):492–494.
  • COVIDNOW in Malaysia: the official Malaysia government website for data and insights on COVID-19. Malaysia: Ministry of Health Malaysia; p. c2021–2022 [cited 2022 Feb 28]. Available from: https://covidnow.moh.gov.my/.
  • Suah JL, Husin M, Tok PS, et al. Waning COVID-19 Vaccine Effectiveness for BNT162b2 and CoronaVac in Malaysia: an observational study. Int J Infect Dis. 2022;119:69–76.
  • Bai J, Perron P. Computation and analysis of multiple structural change models. J Appl Econ. 2003;18(1):1–22.
  • Munro AP, Janani L, Cornelius V, et al. Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial. Lancet. 2021;398(10318):2258–2276.
  • Clemens SAC, Weckx L, Clemens R, et al. Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study. Lancet. 2022;399(10324):521–529.
  • Jara A, Undurraga EA, Zubizarreta JR, et al. Effectiveness of homologous and heterologous booster shots for an inactivated SARS-CoV-2 vaccine: a large-scale observational study. 2022. Located at SSRN: https://ssrn.com/abstract=4005130 or doi:10.2139/ssrn.4005130

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.